Marco Lobba
About Marco Lobba
Marco Lobba CEO and Co-founder
Marco Lobba is the CEO and Co-founder of an enterprise focused on innovative treatments involving protein conjugation and CRISPR-based editors. As a key leader within his organization, Lobba oversees strategic direction and operational execution, leveraging his substantial expertise to drive the company forward.
Marco Lobba Education and Expertise
Marco Lobba holds a PhD from the University of California Berkeley. During his academic journey, he was a student in the laboratories of Nobel Laureate Jennifer Doudna and Matthew Francis, Emeritus Chair of the Berkeley Department of Chemistry. Lobba also earned his bachelor's degree from Pomona College. His expertise lies in protein conjugation, which has played a critical role in advancing CRISPR-based editors and cell-based therapies.
Marco Lobba Background
Marco Lobba has a rich academic background shaped by his time at prestigious institutions. Before stepping into his role as a CEO and Co-founder, Lobba developed his expertise in protein conjugation while studying under influential figures such as Nobel Laureate Jennifer Doudna and Matthew Francis at the University of California Berkeley. His foundational education was completed at Pomona College, where he earned his bachelor's degree.
Marco Lobba Achievements
Marco Lobba's contributions to the field of protein conjugation have advanced innovative treatments, particularly in the realms of CRISPR-based editors and cell-based therapies. His academic work and subsequent professional endeavors demonstrate a commitment to pushing the boundaries of medical and scientific research, fueled by his deep expertise and rigorous training.